Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

EGFR tyrosine kinase inhibitor from Novartis will proceed to clinical testing

April 9, 1998

Mitotix describes novel inhibitors of the CDK/cyclin complexes

April 9, 1998

Novel topoisomerase I inhibitor discovered at Kaken

April 8, 1998

Symphar antineoplastic agent induces apoptosis and reverses MDR

April 8, 1998

HER2 receptor tyrosine kinase inhibitors synthesized at Takeda

April 8, 1998

Zadaxin in combination with TACE shows promise in liver cancer therapy

April 8, 1998

Genta announces issue of patent for lead antisense compound

April 8, 1998

Orphan Medical announces results of Busulfex clinical trials

April 7, 1998

Novel apoptosis-related protease disclosed by Genetics Institute

April 7, 1998

More protein tyrosine kinase inhibitors in the pipeline at Glaxo Wellcome

April 7, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 7, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
Regulatory actions for May 5, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Adma, Applied...